Summary
This 8-K filing by MetLife Inc. on December 9, 2004, primarily discloses the details of a significant debt issuance. MetLife entered into an underwriting and pricing agreement on December 1, 2004, to issue £350 million in aggregate principal amount of 5.375% senior notes due December 9, 2024. These notes were offered and sold primarily outside the United States under Regulation S, with an allowance for resales in the U.S. pursuant to an existing shelf registration statement. The filing incorporates by reference key documents, including the underwriting and pricing agreements, an eleventh supplemental indenture which outlines the terms of the Senior Notes, and the opinion of legal counsel. This issuance represents a strategic move by MetLife to secure long-term financing, the proceeds of which are likely intended for general corporate purposes or to manage its capital structure. Investors should note the terms of the debt, including the interest rate and maturity date, as well as the international offering structure.
Key Highlights
- 1MetLife Inc. issued £350 million in aggregate principal amount of 5.375% senior notes due December 9, 2024.
- 2The debt issuance occurred through underwriting and pricing agreements executed on December 1, 2004.
- 3The senior notes were primarily offered and sold outside the United States under Regulation S.
- 4Up to £35 million of the notes may be resold in the United States under a shelf registration statement.
- 5The terms of the senior notes are governed by an indenture, supplemented by an Eleventh Supplemental Indenture dated December 9, 2004.
- 6Key legal and financial agreements related to the issuance are filed as exhibits to this report.